Follow
Scott L. Friedman
Scott L. Friedman
Professor of Medicine
Verified email at mssm.edu
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13105*2021
Mechanisms of hepatic fibrogenesis
SL Friedman
Gastroenterology 134 (6), 1655-1669, 2008
33762008
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver
SL Friedman
Physiological reviews 88 (1), 125-172, 2008
33002008
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
SL Friedman
Journal of Biological Chemistry 275 (4), 2247-2250, 2000
30222000
Mechanisms of NAFLD development and therapeutic strategies
SL Friedman, BA Neuschwander-Tetri, M Rinella, AJ Sanyal
Nature medicine 24 (7), 908-922, 2018
30202018
Liver fibrosis–from bench to bedside
SL Friedman
Journal of hepatology 38, 38-53, 2003
25722003
Mechanisms of hepatic stellate cell activation
T Tsuchida, SL Friedman
Nature reviews Gastroenterology & hepatology 14 (7), 397-411, 2017
22622017
Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis
E Vilar-Gomez, Y Martinez-Perez, L Calzadilla-Bertot, A Torres-Gonzalez, ...
Gastroenterology 149 (2), 367-378. e5, 2015
21012015
Pathogenesis of liver fibrosis
V Hernandez-Gea, SL Friedman
Annual review of pathology: mechanisms of disease 6, 425-456, 2011
20042011
The cellular basis of hepatic fibrosis--mechanisms and treatment strategies
SL Friedman
New England Journal of Medicine 328 (25), 1828-1835, 1993
18581993
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ...
New England Journal of Medicine 359 (19), 1995-2004, 2008
13292008
Mechanisms of hepatic fibrogenesis
UE Lee, SL Friedman
Best practice & research Clinical gastroenterology 25 (2), 195-206, 2011
11952011
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma
Y Hoshida, SMB Nijman, M Kobayashi, JA Chan, JP Brunet, DY Chiang, ...
Cancer research 69 (18), 7385-7392, 2009
11752009
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
M Müller, S Wilder, D Bannasch, D Israeli, K Lehlbach, M Li-Weber, ...
The Journal of experimental medicine 188 (11), 2033-2045, 1998
11541998
Hepatic stellate cells as key target in liver fibrosis
T Higashi, SL Friedman, Y Hoshida
Advanced drug delivery reviews 121, 27-42, 2017
11292017
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
L Xu, AY Hui, E Albanis, MJ Arthur, SM O’byrne, WS Blaner, P Mukherjee, ...
Gut 54 (1), 142-151, 2005
10992005
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
SL Friedman, FJ Roll, J Boyles, DM Bissell
Proceedings of the National Academy of Sciences 82 (24), 8681-8685, 1985
10741985
Liver cancer cell of origin, molecular class, and effects on patient prognosis
D Sia, A Villanueva, SL Friedman, JM Llovet
Gastroenterology 152 (4), 745-761, 2017
10672017
Pathobiology of liver fibrosis: a translational success story
YA Lee, MC Wallace, SL Friedman
Gut 64 (5), 830-841, 2015
9412015
Mechanisms and disease consequences of nonalcoholic fatty liver disease
R Loomba, SL Friedman, GI Shulman
Cell 184 (10), 2537-2564, 2021
9062021
The system can't perform the operation now. Try again later.
Articles 1–20